Year To Quarter End Consolidated Statement Of Comprehensive Income

Fuji Pharma Co.,Ltd. - Filing #7290798

Concept 2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
5,808,000,000 JPY
6,147,000,000 JPY
5,808,000,000 JPY
5,808,000,000 JPY
5,808,000,000 JPY
JPY
JPY
JPY
3,117,000,000 JPY
3,117,000,000 JPY
3,117,000,000 JPY
3,435,000,000 JPY
3,117,000,000 JPY
JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,529,000,000 JPY
2,253,000,000 JPY
Deferred gains or losses on hedges
7,000,000 JPY
-13,000,000 JPY
Foreign currency translation adjustment
668,000,000 JPY
554,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-5,000,000 JPY
28,000,000 JPY
Other comprehensive income
-858,000,000 JPY
2,823,000,000 JPY
Comprehensive income
5,288,000,000 JPY
6,259,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
5,288,000,000 JPY
6,259,000,000 JPY
Comprehensive income attributable to non-controlling interests
0 JPY
0 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.